Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 763 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from India

Prasanna Kumar K M, Mohan Viswanathan, Sethi Bipin, Gandhi Pramod, Bantwal Ganapathi, Xie John, Meininger Gary, Qiu Rong

Year : 2016| Volume: 20| Issue : 3 | Page no: 372-380

   This article has been cited by
1 Canagliflozin: A Review in Type 2 Diabetes
Emma D. Deeks,André J. Scheen
Drugs. 2017; 77(14): 1577
[Pubmed]  [Google Scholar] [DOI]
2 Single-dose Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Selective Inhibitor of Sodium Glucose Cotransporter 2, in Healthy Indian Participants
Damayanthi Devineni,David Polidori,Christopher Curtin,Hans Stieltjes,Hong Tian,Ewa Wajs
Clinical Therapeutics. 2016; 38(1): 89
[Pubmed]  [Google Scholar] [DOI]


Read this article